BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31630867)

  • 21. Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy.
    Hayami M; Watanabe M; Ishizuka N; Mine S; Imamura Y; Okamura A; Kurogochi T; Yamashita K
    J Surg Oncol; 2018 May; 117(6):1251-1259. PubMed ID: 29205358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: A retrospective cohort study.
    Makiura D; Ono R; Inoue J; Kashiwa M; Oshikiri T; Nakamura T; Kakeji Y; Sakai Y; Miura Y
    J Geriatr Oncol; 2016 Nov; 7(6):430-436. PubMed ID: 27452909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
    Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
    Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy.
    Hsu FM; Lee YC; Lee JM; Hsu CH; Lin CC; Tsai YC; Wu JK; Cheng JC
    Ann Surg Oncol; 2009 Jun; 16(6):1669-77. PubMed ID: 19267157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis.
    Thomas M; Borggreve AS; van Rossum PSN; Perneel C; Moons J; Van Daele E; van Hillegersberg R; Deng W; Pattyn P; Mook S; Boterberg T; Ruurda JP; Nafteux P; Lin SH; Haustermans K
    Acta Oncol; 2019 Oct; 58(10):1358-1365. PubMed ID: 31432736
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac surgery-associated acute kidney injury: risk factors analysis and comparison of prediction models.
    Kristovic D; Horvatic I; Husedzinovic I; Sutlic Z; Rudez I; Baric D; Unic D; Blazekovic R; Crnogorac M
    Interact Cardiovasc Thorac Surg; 2015 Sep; 21(3):366-73. PubMed ID: 26091696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
    Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the impact of preoperative chemoradiotherapy on outcome and postoperative complications in esophageal cancer patients.
    Wilke TJ; Bhirud AR; Lin C
    Am J Clin Oncol; 2015 Aug; 38(4):415-21. PubMed ID: 24351783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
    Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
    Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.
    Shaikh T; Churilla TM; Monpara P; Scott WJ; Cohen SJ; Meyer JE
    Pract Radiat Oncol; 2016; 6(6):388-394. PubMed ID: 27025161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis.
    Sathornviriyapong S; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Kawano Y; Yamada M; Uchida E
    Ann Surg Oncol; 2016 Oct; 23(11):3632-3640. PubMed ID: 27278203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
    Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
    Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the confidence interval in the multivariable normal tissue complication probability model for predicting radiation-induced liver disease in primary liver cancer.
    Prayongrat A; Srimaneekarn N; Sriswasdi S; Ito YM; Katoh N; Tamura M; Dekura Y; Toramatsu C; Khorprasert C; Amornwichet N; Alisanant P; Hirata Y; Hayter A; Shirato H; Shimizu S; Kobashi K
    J Radiat Res; 2021 May; 62(3):483-493. PubMed ID: 33899102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
    Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
    Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer.
    Law S; Wong KH; Kwok KF; Chu KM; Wong J
    Ann Surg; 2004 Nov; 240(5):791-800. PubMed ID: 15492560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.
    van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL;
    Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction Model of Long-term Survival After Esophageal Cancer Surgery.
    Xie SH; Santoni G; Mälberg K; Lagergren P; Lagergren J
    Ann Surg; 2021 May; 273(5):933-939. PubMed ID: 33824250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is pathological complete response after a trimodality therapy, a predictive factor of long-term survival in locally-advanced esophageal cancer? Results of a retrospective monocentric study.
    Francoual J; Lebreton G; Bazille C; Galais MP; Dupont B; Alves A; Lubrano J; Morello R; Menahem B
    J Visc Surg; 2018 Oct; 155(5):365-374. PubMed ID: 29501383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
    Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
    Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
    Elliott JA; O'Byrne L; Foley G; Murphy CF; Doyle SL; King S; Guinan EM; Ravi N; Reynolds JV
    Br J Surg; 2019 Sep; 106(10):1341-1351. PubMed ID: 31282584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.